Please assess the completion status of the following clinical trial:

Trial Title: A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Ability and acceptance to provide written consent~* Men or women between 18-75 years~* Body Mass Index of ≥ 18 and ≤ 30 kg/m2~Exclusion Criteria:~* History (within the 12 months prior to screening) of psychiatric disorders~* Major surgery, trauma, illness or immobile for 3 or more days within the past month~* Pregnancy or recent pregnancy (within 6 weeks)~* A positive test for drugs of abuse at the screening visit~* Any other sound medical reason as determined by the clinical investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- tasimelteon (Type: EXPERIMENTAL): tasimelteon, administered as oral capsule(s)
- Placebo (Type: PLACEBO_COMPARATOR): Placebo, administered as oral capsule(s)

Based on this trial design, predict the completion outcome and termination type (if applicable).